Treasure Sea Limited increases its stake in CMS (00867) by 500,000 shares, with an estimated price of approximately HK$7.55 per share.
On September 19th, Treasure Sea Limited increased its holdings of Kangzhe Pharmaceutical (00867) by 500,000 shares, with a price of 7.546 Hong Kong dollars per share, totaling 3.773 million Hong Kong dollars.
According to the latest information from the Hong Kong Stock Exchange, on September 19th, Treasure Sea Limited increased its holdings of CMS (00867) by 500,000 shares at a price of 7.546 Hong Kong dollars per share, with a total amount of 3.773 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 1.166 billion shares, and the latest shareholding ratio is 47.80%.
This transaction involves another related party: Lin Gang.
Related Articles
US Stock Market Move | Palantir (PLTR.US) fell more than 6.7% in response to its impressive Q3 financial report, but the market is concerned that its valuation is too high.
US Stock Market Move | Royal Philips N.V. Sponsored ADR (PHG.US) rises 3% in Q3, adjusted EBITA exceeds expectations.
US Stock Market Move | Hot Chinese concept stocks generally fell, with Futu Holdings Ltd. Sponsored ADR Class A (FUTU.US) falling more than 5%.
US Stock Market Move | Palantir (PLTR.US) fell more than 6.7% in response to its impressive Q3 financial report, but the market is concerned that its valuation is too high.
US Stock Market Move | Royal Philips N.V. Sponsored ADR (PHG.US) rises 3% in Q3, adjusted EBITA exceeds expectations.
US Stock Market Move | Hot Chinese concept stocks generally fell, with Futu Holdings Ltd. Sponsored ADR Class A (FUTU.US) falling more than 5%.
RECOMMEND
World’s largest oil company Aramco posts higher Q3 net profit after lifting output
04/11/2025
HSBC, General Atlantic CEOs flag AI capex-revenue mismatch, ‘irrational exuberance’
04/11/2025
Pfizer Files Second Lawsuit Against Novo Nordisk and Metsera Amid Intensifying Bidding Battle Over Obesity Biotech
04/11/2025
